NDC 50090-1523
GARDASIL
Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant
GARDASIL is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by A-s Medication Solutions. The primary component is Human Papillomavirus Type 6 L1 Capsid Protein Antigen; Human Papillomavirus Type 11 L1 Capsid Protein Antigen; Human Papillomavirus Type 16 L1 Capsid Protein Antigen; Human Papillomavirus Type 18 L1 Capsid Protein Antigen.
| Product ID | 50090-1523_0150b986-99af-492a-a1de-0b1b2a33a4f5 |
| NDC | 50090-1523 |
| Product Type | Vaccine |
| Proprietary Name | GARDASIL |
| Generic Name | Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2006-06-08 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125126 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN |
| Active Ingredient Strength | 20 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| Pharm Classes | Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [CS],Vaccines, Inactivated [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 50090-1523-1
10 VIAL, SINGLE-DOSE in 1 CARTON (50090-1523-1) > .5 mL in 1 VIAL, SINGLE-DOSE (50090-1523-9)
| Marketing Start Date | 2006-06-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50090-1523-1 [50090152301]
GARDASIL INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125126 |
| Product Type | VACCINE |
| Marketing Start Date | 2006-06-08 |
NDC 50090-1523-9 [50090152309]
GARDASIL INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125126 |
| Product Type | VACCINE |
| Marketing Start Date | 2006-06-08 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN | 20 ug/.5mL |
Pharmacological Class
- Inactivated Human Papillomavirus Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Papillomavirus Vaccines [CS]
- Vaccines
- Inactivated [CS]
- Inactivated Human Papillomavirus Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Papillomavirus Vaccines [CS]
- Vaccines
- Inactivated [CS]
- Inactivated Human Papillomavirus Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Papillomavirus Vaccines [CS]
- Vaccines
- Inactivated [CS]
- Inactivated Human Papillomavirus Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Papillomavirus Vaccines [CS]
- Vaccines
- Inactivated [CS]
NDC Crossover Matching brand name "GARDASIL" or generic name "Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-4045 | GARDASIL | Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant |
| 0006-4109 | GARDASIL | Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant |
| 50090-1523 | GARDASIL | Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant |
Trademark Results [GARDASIL]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GARDASIL 76563892 3015981 Live/Registered |
MERCK SHARP & DOHME CORP. 2003-12-05 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.